PRESS RELEASE published on 01/04/2024 at 19:00, 10 months 16 days ago Atomic Minerals Amends Price of Previously Granted Stock Options Atomic Minerals Corp. has announced the re-pricing of 620,000 outstanding stock options to $0.09 per share, with 280,000 options requiring approval at the upcoming Annual General and Special Meeting. The company aims to identify exploration opportunities in underexplored regions with geological similarities to previous uranium discoveries. For more information, visit www.atomicminerals.ca Stock Options Atomic Minerals Corp. Exploration Opportunities Uranium Projects Geological Similarities
PRESS RELEASE published on 12/23/2023 at 00:05, 10 months 29 days ago Atomic Minerals Grants Stock Options to Directors and Consultants
PRESS RELEASE published on 12/07/2023 at 02:21, 11 months 14 days ago Atomic Minerals Closes First Tranche of Private Placement for CAD $699,408.75
PRESS RELEASE published on 11/24/2023 at 00:30, 11 months 27 days ago Atomic Minerals Concludes Debt Settlement Transaction
PRESS RELEASE published on 11/20/2023 at 19:30, 1 year ago Atomic Minerals Amends Debt Settlement Transaction
PRESS RELEASE published on 11/10/2023 at 22:30, 1 year ago Atomic Minerals to Proceed with Debt Settlement Transaction
PRESS RELEASE published on 11/06/2023 at 14:30, 1 year ago Atomic Minerals Announces Private Placement for Up to CDN $1.0 Million
PRESS RELEASE published on 10/30/2023 at 13:30, 1 year ago Atomic Minerals offers Comment on Uranium Market Following Significant Price Increase
PRESS RELEASE published on 10/16/2023 at 22:05, 1 year 1 month ago CORRECTION: Atomic Minerals Proceeds to Consolidation
PRESS RELEASE published on 10/16/2023 at 18:00, 1 year 1 month ago Atomic Minerals Proceeds to Consolidation
Published on 11/21/2024 at 13:30, 36 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 36 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 31 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 51 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 8 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 46 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 21 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 21 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo